Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/20/24 16:04 | 9/25/24 | CERO | Health | BioPrd | Biological Products, (No Diag | Sloan Stuart M | WA | T | S | -56 | 0.1043 | 0 | -532 | -2 | 21,068 | I | |||||||||||||||
11/14/24 20:14 | 10/10/24 | CERO | Health | BioPrd | Biological Products, (No Diag | Yk Bioventures Opportunities Gp I, LLC | CA | T | S | -325 | 0.1000 | 0 | -3,250 | -13 | 22,621 | I | |||||||||||||||
10/2/24 21:53 | 9/25/24 | CERO | Health | BioPrd | Biological Products, (No Diag | Laporte Kathleen | CA | D | M.d | 0 | 0.00 | 0 | 966 | 999% | 972 | I | |||||||||||||||
10/2/24 21:53 | 9/25/24 | CERO | Health | BioPrd | Biological Products, (No Diag | Ehrlich Christopher B | CA | DO | Interim | M.d | 0 | 0.00 | 0 | 5,313 | 999% | 5,795 | D | ||||||||||||||
10/2/24 21:52 | 9/25/24 | CERO | Health | BioPrd | Biological Products, (No Diag | Atwood Brian G | CA | D | M.d | 0 | 0.00 | 0 | 19,359 | 999% | 19,732 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |